
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Preclinical Pharmacology |
Department of Thoracic/Head and Neck Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 [H-Y. L., Y-A. S., J. I. L., K. A. H., L. M., J. M. K.]; Molecular Cardiology Research Institute, New England Medical Center, Boston, Massachusetts 02111 [T. F.]; Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas 77030 [B. E. G.]; and Howard Hughes Medical Institute, Center for Cancer Research, and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 [T. J.]
Purpose: Transfer of growth-suppressive genes to lung tumors has therapeutic potential, but effective delivery techniques have not been developed. Here, we investigated gene delivery to lung tumors by aerosolization of adenoviral vectors incorporated into calcium phosphate precipitates.
Experimental Design: To investigate the efficacy of this delivery method in normal and neoplastic lung, an adenoviral vector expressing ß-galactosidase was administered by jet nebulization to K-rasLA1 mice, which develop lung adenocarcinomas through activation of a latent allele carrying mutant K-ras(G12D). Furthermore, we investigated whether aerosolized delivery of Ad-MKK4 (KR), an adenoviral vector expressing dominant-negative mutant mitogen-activated protein kinase kinase 4(MKK4), can block Ras-dependent signaling in K-rasLA1 mice.
Results: After a single administration, ß-galactosidase was detected in lung tissue for up to 21 days, and expression was much greater in tumors than in normal lung tissue. MKK4 was activated in the lungs of K-rasLA1 mice, and aerosolized treatment with Ad-MKK4 (KR) decreased c-Jun-NH2-terminal kinase but not extracellular signal- regulated kinase activity, providing evidence that MKK4 was selectively inhibited.
Conclusions: These findings demonstrate a novel approach to targeting oncogenic pathways in lung tumors by aerosolized gene delivery.
This article has been cited by other articles:
![]() |
Y. Zou, C. Tornos, X. Qiu, M. Lia, and R. Perez-Soler p53 Aerosol Formulation with Low Toxicity and High Efficiency for Early Lung Cancer Treatment Clin. Cancer Res., August 15, 2007; 13(16): 4900 - 4908. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Haigis, I. I. Wistuba, and J. M. Kurie Lung premalignancy induced by mutant B-Raf, what is thy fate? To senesce or not to senesce, that is the question Genes & Dev., February 15, 2007; 21(4): 361 - 366. [Full Text] [PDF] |
||||
![]() |
D. Dankort, E. Filenova, M. Collado, M. Serrano, K. Jones, and M. McMahon A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors Genes & Dev., February 15, 2007; 21(4): 379 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xia, H. Srinivas, Y.-h. Ahn, G. Sethi, X. Sheng, W. K. A. Yung, Q. Xia, P. J. Chiao, H. Kim, P. H. Brown, et al. Mitogen-activated Protein Kinase Kinase-4 Promotes Cell Survival by Decreasing PTEN Expression through an NF{kappa}B-dependent Pathway J. Biol. Chem., February 9, 2007; 282(6): 3507 - 3519. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wislez, N. Fujimoto, J. G. Izzo, A. E. Hanna, D. D. Cody, R. R. Langley, H. Tang, M. D. Burdick, M. Sato, J. D. Minna, et al. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res., April 15, 2006; 66(8): 4198 - 4207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wislez, M. L. Spencer, J. G. Izzo, D. M. Juroske, K. Balhara, D. D. Cody, R. E. Price, W. N. Hittelman, I. I. Wistuba, and J. M. Kurie Inhibition of Mammalian Target of Rapamycin Reverses Alveolar Epithelial Neoplasia Induced by Oncogenic K-ras Cancer Res., April 15, 2005; 65(8): 3226 - 3235. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Srinivas, D. M. Juroske, S. Kalyankrishna, D. D. Cody, R. E. Price, X.-C. Xu, R. Narayanan, N. L. Weigel, and J. M. Kurie c-Jun N-Terminal Kinase Contributes to Aberrant Retinoid Signaling in Lung Cancer Cells by Phosphorylating and Inducing Proteasomal Degradation of Retinoic Acid Receptor {alpha} Mol. Cell. Biol., February 1, 2005; 25(3): 1054 - 1069. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |